메뉴 건너뛰기




Volumn 145, Issue 8, 2009, Pages 923-925

Cutaneous pigmentation after photosensitivity induced by vandetanib therapy

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; EMOLLIENT AGENT; FLUOCINOLONE ACETONIDE; HYDROQUINONE; RETINOID; STEROID; SUNSCREEN; TEMOZOLOMIDE; VANDETANIB;

EID: 68949093952     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.177     Document Type: Article
Times cited : (37)

References (6)
  • 1
    • 34948838898 scopus 로고    scopus 로고
    • Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer
    • Heymach JV, Johnson BE, Prager D, et al. Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer. J Clin Oncol. 2007;25(27):4270-4277.
    • (2007) J Clin Oncol , vol.25 , Issue.27 , pp. 4270-4277
    • Heymach, J.V.1    Johnson, B.E.2    Prager, D.3
  • 2
    • 33846844387 scopus 로고    scopus 로고
    • A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors
    • Tamura T, Minami H, Yamada Y, et al. A phase I dose-escalation study of ZD6474 in Japanese patients with solid, malignant tumors. J Thorac Oncol. 2006;1(9):1002-1009.
    • (2006) J Thorac Oncol , vol.1 , Issue.9 , pp. 1002-1009
    • Tamura, T.1    Minami, H.2    Yamada, Y.3
  • 3
    • 41749097667 scopus 로고    scopus 로고
    • A randomized, double-blind, phase IIa dosefinding study of vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer
    • Kiura K, Nakagawa K, Shinkai T, et al. A randomized, double-blind, phase IIa dosefinding study of vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer. J Thorac Oncol. 2008;3(4):386-393.
    • (2008) J Thorac Oncol , vol.3 , Issue.4 , pp. 386-393
    • Kiura, K.1    Nakagawa, K.2    Shinkai, T.3
  • 4
    • 21344462378 scopus 로고    scopus 로고
    • Cutaneous side-effects of kinase inhibitors and blocking antibodies
    • Robert C, Soria JC, Spatz A, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol. 2005;6(7):491-500.
    • (2005) Lancet Oncol , vol.6 , Issue.7 , pp. 491-500
    • Robert, C.1    Soria, J.C.2    Spatz, A.3
  • 5
    • 29144510498 scopus 로고    scopus 로고
    • The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice
    • Ko J, Ross J, Awad H, Hurwitz H, Klitzman B. The effects of ZD6474, an inhibitor of VEGF signaling, on cutaneous wound healing in mice. J Surg Res. 2005;129(2):251-259.
    • (2005) J Surg Res , vol.129 , Issue.2 , pp. 251-259
    • Ko, J.1    Ross, J.2    Awad, H.3    Hurwitz, H.4    Klitzman, B.5
  • 6
    • 0034906831 scopus 로고    scopus 로고
    • Drug-induced skin pigmentation: Epidemiology, diagnosis and treatment
    • Dereure O. Drug-induced skin pigmentation: epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2(4):253-262.
    • (2001) Am J Clin Dermatol , vol.2 , Issue.4 , pp. 253-262
    • Dereure, O.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.